Dual Wavelength OCT
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03843840 |
Recruitment Status : Unknown
Verified February 2019 by Moorfields Eye Hospital NHS Foundation Trust.
Recruitment status was: Recruiting
First Posted : February 18, 2019
Last Update Posted : February 18, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
AMD Diabetic Retinopathy Retinal Degeneration Retinal Dystrophies | Device: Combined Coaxial Optical Coherence Tomography |
Study Type : | Observational |
Estimated Enrollment : | 200 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Combined Coaxial Optical Coherence Tomography System to Image the Retina and Choroidal Structures and Estimate Tissue Reflectivity in Healthy and Diseased Retinas |
Actual Study Start Date : | February 15, 2019 |
Estimated Primary Completion Date : | July 31, 2019 |
Estimated Study Completion Date : | September 30, 2019 |
Group/Cohort | Intervention/treatment |
---|---|
Diseased Retina |
Device: Combined Coaxial Optical Coherence Tomography
Taking images of the retina with two wavelengths |
- Test retest reliability [ Time Frame: 14 months ]Comparison of device test retest variability with those of standard OCT for measurement of tissue reflectivity.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Age>18
- Ability to consent
- Abnormal reflectivity detected in at least one eye in the retina or choroid on OCT testing undertaken as part of routine
- clinical care
Exclusion Criteria:
- Media opacities on conventional OCT testing taken on the day of the study visit, that prevents adequate visualisation of
- the retina and/or choroidal substructures in the opinion of the investigator
- Inability to undertake to undertake two additional OCT scans on each eye in addition to their conventional OCT.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03843840
Contact: Adnan Tufail | 020 7253 3411 ext 2036 | adnan.tufail@nhs.net |
United Kingdom | |
Moorfields Eye Hospital NHS Foundation Trust, 162 City Road | Recruiting |
London, United Kingdom, EC1V 2PD | |
Contact: Tania West 020 7253 3411 moorfields.resadmin@nhs.net |
Responsible Party: | Moorfields Eye Hospital NHS Foundation Trust |
ClinicalTrials.gov Identifier: | NCT03843840 |
Other Study ID Numbers: |
TUFA1040 |
First Posted: | February 18, 2019 Key Record Dates |
Last Update Posted: | February 18, 2019 |
Last Verified: | February 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Diabetic Retinopathy Retinal Degeneration Retinal Dystrophies Retinal Diseases Eye Diseases Diabetic Angiopathies |
Vascular Diseases Cardiovascular Diseases Diabetes Complications Diabetes Mellitus Endocrine System Diseases Eye Diseases, Hereditary |